Syngene stock price dropped after management issued cautious outlook during quarterly results. The company has reduced FY24 guidance due to slowdown in the US biotech segment.
Market analyst Mitesh Thakkar has suggested four BUY Calls and no SELL Call for today’s trading session.
Pfizer announced that its vaccine developed by a German health startup has 90 percent efficacy.
Research house and brokerage Motilal Oswal has suggested BUY Call for pharmaceutical major Aurobindo Pharma with a target price of Rs 985.
Ace investor Rakesh Jhunjhunwala has raised his stake in Lupin during the last quarter. Pharmaceutical sector has witnessed strong performance after COVID-19 pandemic led to lockdowns.
Pharmaceutical major Wockhardt has signed a deal with the UK government to supply COVID-19 vaccine under development and testing by AstraZeneca and researchers from Oxford University.
© 2005-2023 TOPNEWS.IN ALL RIGHTS RESERVED. COPYSCAPE PROTECTED